Physician profile
Luisa Galdi
NPI 1669780565
$557.32
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $172 · 2020: $35.15 · 2021: $249 · 2022: $43.36 · 2023: $57.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $57.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $57.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gynesonics, INC. | $193.34 | 2021 | |
| Abbvie INC. | $136.52 | 2019-2021 | |
| Applied Medical Resources Corporation | $57.86 | 2023 | Gelpoint V-Path |
| Pfizer INC. | $43.36 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.96 | 2019 | |
| Hologic Sales and Service, LLC | $25.14 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $19.76 | 2019 | |
| Amag Pharmaceuticals, INC. | $19.19 | 2019 | |
| Agile Therapeutics, INC. | $15.64 | 2021 | |
| Therapeuticsmd, INC. | $14.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luisa Galdi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.